This open forum series will be conducted the second Thursday of each month from 1:00-2:00pm ET.
Each open forum will be moderated by APhA President Theresa Tolle. We welcome all of pharmacy to join us for the upcoming live webinar using the registration link below. The recordings will be made available below to APhA members only.
Past Open Forums
February 22nd: Track-and-Trace (DSCSA) with FDA and NABP
Discuss what you need to know to comply with new electronic requirements under the DSCSA law that will take effect this November.
January 20th: New Year, New Congress: Pharmacy Priorities in 2023
Hear from APhA’s government affairs team as they break down what you need to know about the new Congress and how these newly elected policymakers will shape pharmacy advocacy priorities this year.
January 4th: Special Edition: Drug Shortages with FDA
During this special edition of APhA’s Pulse on Practice and Policy Open Forum Series, we will discuss the drug shortages pharmacies are facing nationwide. The open forum will feature a representative from FDA who will talk about the factors driving these shortages and the steps FDA is taking to mitigate the impact on patient care. Moderated by APhA’s Interim EVP & CEO, Ilisa Bernstein, we will also welcome health-system and community pharmacy leaders who will share practical strategies pharmacy teams can use to help patients find alternatives and explain the situation as demand for certain medications continues.
December 15th: OTC Hearing Aids
Discuss what pharmacists should know about OTC hearing aids and the role pharmacists can have in expanding access to hearing care.
- Lucas A. Berenbrok, PharmD, MS, BCACP, TTS, Associate Professor of Pharmacy & Therapeutics, University of Pittsburgh School of Pharmacy
- Elaine Mormer, PhD, CCC-A, Professor & Vice President for Clinical Education, Communications Science & Disorders, University of Pittsburgh
November 10th: New Strategies for Improving Pharmacy Team Well-being
Pharmacists and their teams are increasingly being asked to do more with less as unsustainable pharmacy business models impact working conditions and well-being. During this open forum we discuss approaches for creating a positive work environment among pharmacy team members and hear from Walgreens about their recent announcement to eliminate task-based metrics from performance reviews.
- Dorothy Loy, PharmD, MBA, Senior Director, Patient Outcomes and Pharmacy of the Future, Walgreens
- Saswat Kabisatpathy, PharmD, MS, BCMTMS, Chief Strategic Officer, Avant Pharmacy and Wellness
October 13th: Criminalization of Medication Errors: The Need for Just Culture
After some of the most demanding years in health care, the recent conviction of former registered nurse RaDonda Vaught, following a fatal medication error, has sparked new concerns about the criminalization of medication errors. Join us to discuss the implications of criminalization actions for medication errors made by health care professionals, including pharmacists and pharmacy teams, and the need for implementation of just culture across pharmacy settings.
- Shelly Nance, PharmD, BCACP, CDCES, CPPS, Corporate Patient Safety Manager for Kroger Health
- Melissa Skelton Duke, PharmD, MS, BCPS, FAPhA, Executive Director, Population Health Pharmacy Solutions, Banner Pharmacy Services
- John Kirtley, PharmD, Executive Director, Arkansas Board of Pharmacy
September 8th: Navigating Pharmacy Practice Post-Dobbs Decision
An informational overview of the latest legal and regulatory actions in the states to date, and a review of medications that can be used for abortion and emergency contraception.
- Veronica Vernon, PharmD, Associate Professor of Pharmacy Practice at Butler College of Pharmacy and Health Sciences
- Kala Shankle, JD, Associate, Epstein Becker & Green
August 11th: Implementing Test to Treat Services for Paxlovid
Discuss how pharmacists are leading efforts to implement test to treat services and ongoing challenges.
- Tory Grooms, PharmD, Clinical Pharmacist, Moose Pharmacy
- Kelly Kent, PharmD, Co-Owner, Towncrest Pharmacy
July 14th: Implementing Test to Treat for Paxlovid
Discuss the conditions under which pharmacists can order and prescribe Paxlovid and key considerations for implementing test to treat services, including reimbursement.
- Florin Draica, MD, CMD, MBA, US Senior Medical Director, HQ Team Lead Anti-Infectives, North America Medical Affairs, Pfizer Hospital
- Shelita Dattani, PharmD, RPh, Vice President, Pharmacy Affairs, Neighbourhood Pharmacy Association of Canada
June 9th: The New Federal Provider Status Legislation
During this open forum, we discussed the latest federal provider status legislation, including how this legislation could help expand access to pharmacists' services and address gaps in health equity. Our panelists also discussed the latest state legislative activities and an innovative ACT Pharmacy Collaborative advocacy program.
Panelists: Ilisa Bernstein, PharmD, JD, FAPhA; Melissa McGivney, PharmD, FCCP, FAPhA; and Michael Murphy, PharmD, MBA